RPAM
MLTX icon

Rhenman & Partners Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MLTX Stock Details MLTX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.12M Hold
45,000
– – 0.27% 70
2025
Q1 		$1.76M Buy
+45,000
New +$1.76M 0.2% 72